Liver glycogen formation can occur via the direct (glucose glucose-6-phosphate -v glycogen) or indirect (glucose -. C3 compounds --glucose-6-phosphate -3 glycogen) pathways. In the present study we have examined the effect of hyperglycemia on the pathways of hepatic glycogenesis, estimated from liver uridine diphosphoglucose (UDPglucose) specific activities, and on peripheral (muscle) glucose metabolism in awake, unstressed control and 90% pancreatectomized, diabetic rats.
Introduction
When a glucose load is administered in the fasting or postabsorptive state, the liver switches from net glucose production to net glucose uptake (1) (2) (3) (4) (5) (6) , and liver glycogen stores are repleted. However, it is now well established, that, after glucose administration, in both animals (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) and humans (21) (22) (23) (24) , a significant portion of liver glycogen is not repleted through the classi-cose -glycogen. Several studies suggest that in non-insulindependent diabetes mellitus (NIDDM), the contribution ofgluconeogenesis to hepatic glucose output is increased, and plays a major role in the augmented plasma glucose concentration and hepatic glucose production during the postabsorptive state (25) (26) (27) .
Recent observations also suggest that the inhibition of lactate/alanine gluconeogenesis by insulin may be mediated via diversion of three-carbon compounds toward other pathways, namely oxidation and glycogen formation (28) , rather than via an insulin-induced reduction of the influx of these substrates into the liver. Thus, insulin may inhibit the gluconeogenic flux to plasma glucose at the level of glucose-6-phosphate, where it directs the newly formed glucose to glycogen instead to plasma. Consistent with this hypothesis, ifgluconeogenesis is increased in the diabetic state, the contribution ofthe indirect (gluconeogenic) pathway to the liver glycogen repletion would also be expected to be altered. In fact, since physiological insulin concentrations have been shown to decrease the hepatic mRNA level of phosphoenolpyruvate-carboxy-kinase (29) , independently of glucagon and cyclic AMP, it may be suggested that prolonged insulin deficiency and/or hepatic insulin resistance may determine an increase in overall gluconeogenic flux, involving both hepatic glucose output and glycogen formation. However, an alternative hypothesis may predict a diversion of gluconeogenic flux away from glycogen synthesis and toward glucose-6-phosphatase, at the level of the glucose-6-phosphate pool, thus without any alteration in the contribution of this pathway to liver glycogen repletion.
To delineate the impact of the diabetic state on the direct versus indirect pathways ofliver glycogen repletion, we studied control and diabetic conscious rats under identical conditions of hyperinsulinemia and measured the specific activity of hepatic UDPglucose, the direct precursor of glycogen, at the end of the insulin clamp study. This allowed us to examine the pathways of liver glycogen repletion independently from the basal glycogen concentration. Because the circulating plasma glucose concentration is believed to be the major determinant of the pathways by which liver glycogen is repleted in normal rats (14, 17) , we also examined the relationship between the plasma glucose concentration and hepatic glycogenesis by the direct vs. indirect pathway in conscious unrestrained control and diabetic (90% pancreatectomized) rats.
Methods
Animals. Two groups of male Sprague-Dawley rats (Charles River Breeding Laboratories, Inc., Wilmington, MA) were studied: group I, sham-operated controls (n = 26); group II, partially pancreatectomized rats (n = 18). At Muscle glycogen formation in vivo. Muscle glycogen synthesis was quantitated by two independent means: first, by determining the increment in cold glycogen concentration above fasting levels, and second, by measuring the incorporation of [3-3H] glucose counts into glycogen. Muscle glycogen concentrations were determined after digestion with amyloglucosidase as previously described (32) (33) (34) (35) (36) . The intraassay and the interassay coefficients of variation were < 10% (at 14.0 mmol of glucosyl units in glycogen per kilogram oftissue weight) when a muscle homogenate was assayed as multiple aliquots. The fasting glycogen concentration was measured in a separate group of 30 rats who were treated in a fashion identical (i.e., diet, housing, catheter insertion, 24-h fast, sacrifice, etc.) to that ofthe rats in groups I and II. Aliquots of the tissue homogenate (200 Ml) were employed to determine the amount of tritium label in glycogen. The recovery of free [3-3H] glucose, added to test the procedure, was < 1% ofthe free glucose radioactivity added to the homogenate in each assay. The glycogen synthetic rate was obtained by dividing the radioactivity of [3-3H] Whole-bodyglycolyticfilux in vivo. Because tritium on the C-3 position ofglucose is lost to water during glycolysis, it can be assumed that, when [3-3H] glucose is infused, plasma tritium is present either in 3H20 or [3-3H] glucose (37) . Although tritium may also be released during fructose-6-phosphate cycling and/or pentose phosphate cycling, these pathways account for only a small percentage of the whole-body glucose turnover (38) (39) (40) . Thus, in the studies in which [3-3H] glucose was infused, aliquots ofplasma were precipitated with Ba(OH)2 and ZnSO4 and centrifuged; plasma tritiated water specific activity was determined by liquid scintillation counting of the protein-free supernatant (Somogyi filtrate) before and after evaporation to dryness. Rates of whole-body glycolysis were estimated from the increment per unit time in tritiated water (disintegrations per minute per liter per minute) times the body water mass (liters) divided by the [3-3H]glucose specific activity (disintegrations per minute per micromole). Plasma water was assumed to be 93% ofthe total plasma volume and total body water mass was assumed to be 65% ofthe body mass (32) . The calculation ofglycolytic flux using the above approach assumes that the appearance of 3H20 in plasma is representative of the appearance in the whole body and that the loss of 3H20 during the 2 h ofthe experiment is negligible.
Both ofthese assumptions were previously experimentally validated by performing saline infusions or clamp studies in normal (n = 10) and diabetic (n = 10) rats in combination with a constant infusion of 3H20 (32 (1) . Plasma lactate concentrations and liver glucose-6-phosphate concentrations were measured spectrophotometrically as described by Noll (41) and by Michal (42) . UDPglucose and PEP concentrations and specific activities in the liver were obtained through two sequential chromatographic separations, by a modification of the method previously described (43). Briefly, the first is performed on a solid-phase, strong anion-exchange cartridge, with the use of phosphate buffers of increasing molarity. This first purification allows to partially separate the two compounds ofinterest from all nonpolar and the most of the polar intracellular substrates with optimal recoveries. The second step is a reversed phase, ion pairing HPLC isocratic method, on a C,8 column (Fig. 1) . In order to provide evidence for the identity and purity of the chromatographic peaks, specific precolumn enzymatic conversions of UDPglucose and PEP were carried out. When these samples were injected into the HPLC system, no interfering peaks were eluted within the retention volumes of both PEP and UDPglucose (43).
Results
General characteristics of the animals. There were no differences in the mean body weights between control and diabetic rats (Table I) . Both the fasting (P < 0.05) and post-meal (P < 0.01) plasma glucose concentrations during the 2-wk period before the insulin clamp studies were significantly higher in the diabetic compared to the control group (Table I ). The fasting plasma insulin concentrations were similar, whereas the postmeal plasma insulin concentration were significantly diminished in diabetic rats compared to controls (P < 0.01). Fasting free fatty acid and lactate concentrations were also similar in the two groups (Table I) Insulin clamp studies. Steady-state plasma glucose and insulin concentrations during the insulin clamp studies were similar in the two groups (Table II) . Steady-state conditions for both plasma glucose concentration and specific activity were reached within 30 min (Fig. 2) . The coefficient of variation in plasma glucose level was > 5% in all studies. Hepatic glucose production was almost completely suppressed during all the clamp studies in both diabetic (3.1±1.6, 2.9+0.6, and 2.8±1. 3 ,umol/kg * min) and control rats (3.0±1.8, 2.2±0.9, and 2.1 ± 1.0 ,umol/kg * min during the euglycemic, +5.5 mM and + 1 mM clamp, respectively). During the euglycemic, hyperinsulinemic clamp study, the tissue glucose uptake (Fig. 3 A) (Fig. 3 A) , the tissue glucose uptake in the diabe rats, compared to control rats, was again significantly reduc Muscle glycogen synthesis. After the 24-h fast, the mus4 glycogen concentration was similar in the control (30.1 ±( mmol/kg tissue wt) compared to the diabetic (29.4±0.2 mm( kg tissue wt) group. The determination ofthe rate ofnet muss glycogen synthesis from the tracer incorporation in glycog and from the increment in cold glycogen concentration, ga similar results (32) (33) (34) (35) (36) . vs. 166±12.0 Amol/kg min; diabetic vs. control rats, respectively; P < 0.01 or less). In the hyperglycemic studies, the in-I crease in muscle glycogen synthesis above that observed during the euglycemic clamp was similar in the two groups (+5.5 mM -+ 15.1±2.0 vs. + 16.8±4.8 mmol/kg tissue wt; +11 mM +24.1±2.5 vs. +29.1±3.6 mmoles/kg tissue wt; diabetic vs. control rats, respectively, P = NS).
Whole-body glycolytic flux. During the hyperinsulinemic, euglycemic clamp studies, the whole-body glycolysis in control rats represented 52.9% of the whole-body glucose uptake, whereas it was 65.4% in the diabetic rats. However, the total ; .A.; i. glycolytic flux (Fig. 3 C) (Fig. 5) . In a series of studies, [3-3H] glucose and [U-'4C]lactate were infused (n = 4) and the ratio of the specific activities between 3H-labeled hepatic UDPglucose and portal vein plasma glucose furnished a measure of the direct pathway, while the ratio of specific activities between '4G-labeled hepatic UDPglucose and PEP measured the percent contribution of the indirect pathway. As shown in Table III studies. The contribution ofglucose cycling and PEP gluconeogenesis to overall glucose output can also be calculated from the data in Table III . The hepatic glucose production was 2.5±0.3 ,mol/kg * min in this subset ofrats; the glucose cycling was not different from basal (4.2±0.4 vs. 3.9±0.3 umol/ kg min) and the PEP gluconeogenesis was 2.1 ,mol/kg. min. The ratio ofportal vein plasma lactate and hepatic PEP specific activities provides a measure of the dilution of the '4C label in the oxalacetate pool, and was 1.76 (n = 4). In separate experiments, [3-3H,U-'4C]glucose was infused, and a minimal estimation of the contribution ofthe indirect pathway to glycogen repletion was obtained by comparing the ratio of the relative specific activities of 3H-and '4C-labeled UDPglucose and portal vein plasma glucose while the contribution of the direct pathway was calculated from the ratio of specific activities of 3H-labeled UDPglucose and plasma glucose. The minimal esti- (Table IV) . The direct pathway ofliver glycogen formation was significantly less stimulated in diabetic rats during both the hyperglycemic clamp studies (+5.5 mM-32±5% vs. 51±4%; + 11 mM-38±3% vs. 63±4%; diabetic vs. control rats, P < 0.01). Fig. 5 depicts the contribution of the two pathways. [3-3H] UDPglucose specific activity in skeletal muscle was similar to peripheral plasma glucose specific activity in all the studies. Concentrations ofglucose-6-phosphate and UDPglucose in the liver. The glucose-6-phosphate concentrations (Fig. 6 A) measured in liver homogenates collected at the end ofthe 120-min euglycemic clamp studies, were not statistically different between the two groups (182±14 and 196±20 gmol/kg tissue wt, control and diabetic rats, respectively). At the end of both the hyperglycemic clamp studies the glucose-6-phosphate concentration was markedly and significantly increased, when compared with euglycemia, in both groups (+5.5 mM-316±24 and 347±34 gmol/kg tissue wt; +11 mM-326±31 and 325±43 ,umol/kg tissue wt, control and diabetic rats, respectively). Liver UDPglucose concentrations (Fig. 6 B) at the end of the 120-min euglycemic clamp studies were similar between the two groups (285±24 and 266±23 ,mol/kg tissue wt, control and diabetic rats, respectively). However, when hyperglycemia was added over hyperinsulinemia, liver UDPglucose concentrations were markedly and progressively decreased in control rats (+5.5 mM-163±19 ,umol/kg tissue wt; +11 mM -113±29 ,umol/kg tissue wt), whereas in diabetic rats the hepatic UDPglucose concentration was unchanged during the +5.5 mM (326±22 umol/kg tissue wt) and was significantly decreased only during the +11 mM hyperglycemic clamp (214±27 gmol/kg tissue wt; P < 0.05 vs. euglycemia). At both hyperglycemic levels the hepatic UDPglucose concentration was twofold increased in diabetic compared to control rats (P < 0.01).
Discussion
In the present study we examined the effect of hyperglycemia, under identical conditions of hyperinsulinemia, on the major pathways of glucose metabolism in conscious control and diabetic rats.
As previously reported (32, 34, 35) , under euglycemic hyperinsulinemic conditions, diabetic rats demonstrate a major defect in skeletal muscle glycogen deposition, which completely accounts for the reduction in insulin-mediated wholebody glucose metabolism. When hyperglycemia was added over hyperinsulinemia, glycolysis was not further stimulated in either group, whereas muscle glycogen synthesis was markedly increased. This is consistent with the notion that, when the effect of hyperglycemia on glucose disposal is evaluated at high insulin concentrations, it determines a selective stimulation of glycogen synthesis, although the glycolytic pathway is not further increased over the level achieved with hyperinsulinemia alone (44) . Diabetic rats displayed a significant decrease in insulin-mediated glucose uptake and in muscle glycogen synthesis at all the plasma glucose concentrations examined. However, the increment in skeletal muscle glycogen deposition induced by the increase in blood glucose concentration was similar in diabetic compared to control rats. This suggests that, in diabetic rats, under conditions of identical hyperinsulinemia, the stimulatory effect of hyperglycemia on the wholebody glucose disposal and on muscle glycogen synthesis is normal. The mass effect of hyperglycemia on overall and skeletal muscle glucose metabolism in the diabetic state has been examined by several investigators (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) . Baron et al. (46) showed that the mass effect ofhyperglycemia is preserved in insulin-resistant individuals. A similar conclusion was reached by the forearm balance technique by Capaldo et al. (47), who suggested that the mass effect ofhyperglycemia on forearm glucose uptake in non-insulin-dependent diabetics is actually increased and compensates for insulin resistance, and by Revers et al. (48) and Henry et al. (49) at the whole-body level.
Over the last several years, numerous studies have suggested that, when a glucose load is administered to animals (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) or humans (21-24), a large portion ofthe liver glycogen is repleted by the indirect pathway. This issue has been addressed by several isotopic approaches, mainly based upon the detritiation ofglucose in the indirect pathway, or the determination of the randomization of labeling carbons in UDPglucose (extracted from urine glycoconjugates) or glucosyl units in glycogen. In the present study, the contribution of the two pathways to liver glycogen repletion has been determined from the specific activities of hepatic UDPglucose and PEP, measured by HPLC (43). In this study, the contribution of the direct pathway to hepatic glycogen synthesis during the +5.5 mM and the + 1 mM hyperglycemic clamp studies was severely decreased in diabetic compared to control rats (32% vs. 51% and 38% vs. 63%, respectively). Moreover, the net rate of liver glycogen synthesis was normal in diabetic rats and the absolute gluconeogenic flux to glycogen was markedly increased. These findings suggest that gluconeogenesis is the predominant mechanism by which diabetic rats replete their hepatic glycogen stores and may compensate for the decreased direct incorporation ofglucose into glycogen. However, it should be noted that the contribution of the pathways to liver glycogen repletion may vary as a function ofthe plasma insulin concentration and of the route of glucose administration (2) .
The specific activity of UDPglucose will reflect the specific activity ofthe newly formed glycogen and measures the contribution of the direct pathway to liver glycogen repletion at a specific time point. A major advantage of this method is its independence from the basal glycogen concentration. This is particularly important when evaluating hepatic glycogen synthesis in diabetic rats, in that they present high and variable glycogen concentrations even after 24-48-h fast (54, 55) . The choice ofthe tracers deserves some comments. The ideal tracer for the determination of the direct pathway of liver glycogen repletion would be the one whose label is retained only in the reactions glucose --glucose-6-phosphate --glucose-1 -phosphate -> UDPglucose --glycogen, and lost in water in every other pathway. The two tracers that better respond to these criteria are [3-3H] glucose and [6-3H] glucose (1 1, 12, 14, 15, 17-24, 56-72) . The [6-3H] glucose carbon skeleton, however, retains a small percentage ofthe tritium label during its metabolism through glycolysis and in the tricarboxylic acid cycle. Thus, with the use of this tracer, the direct pathway of liver glycogen repletion may be overestimated. This may represent a problem particularly if a portion of the indirect pathway is intrahepatic and if the extent of this tracer error is predicted to be different in the experimental groups, i.e., diabetic state. [3- 3H]Glucose loses completely the label in its passage through glycolysis. However, a small percentage of [3-3H] glucose may also enter the pentose phosphate pathway, undergo detritiation at the ribulose-5-phosphate level, and reenter in the glucose-6-phosphate pool (56, 57) . In fact, for each molecule of [3-3H] glucose that enters the pentose phosphate pathway (generating three CO2 and one glyceraldehyde-3-phosphate), about two other detritiated molecules of [3-3H] glucose-6-phosphate may reenter the glucose-6-phosphate pool and therefore dilute its specific activity. Thus, this tracer will determine an underestimation of the direct pathway that is in direct proportion to the rate of the pentose phosphate cycle. Because the pentose phosphate cycle has been shown to be negligible in these experimental conditions (24) and, perhaps more importantly, it has been reported to be normal or decreased in diabetic animals (57, 72) Our results confirm that in the postabsorptive state the indirect pathway ofhepatic glycogen repletion plays a predominant role (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . In control rats, the per cent contribution of the direct pathway to hepatic glycogen repletion was 13% and 51% during the euglycemic and the +5.5 mM hyperglycemic insulin clamp studies respectively, in close agreement with previous results obtained, under identical experimental conditions, by nuclear magnetic resonance spectroscopy (7) . As suggested by Newgard et al. (12) , Lang et al. (14) , and Shulman et al. (7), the relative contribution of the direct pathways in control rats is mainly determined by the plasma glucose concentration and by the rates of hepatic glucose uptake.
Our experimental design allows the evaluation ofthe pathways of hepatic glycogen synthesis under identical hyperglycemic and hyperinsulinemic conditions in diabetic compared to control rats. Interestingly, diabetic rats, despite a reduced contribution of the direct pathway to liver glycogen synthesis, maintained similar rates of hepatic glycogen formation. Since glucose-6-phosphate can be formed in the liver either by the direct phosphorylation of glucose or via the gluconeogenic pathway, this may suggest that, in diabetic rats, the increased gluconeogenic flux in the glucose-6-phosphate pool may compensate for the decreased direct uptake ofglucose. Recent studies suggest the presence of an homeostatic mechanism which regulates hepatic glucose production in normal dogs (73) and humans (74, 75) . Our findings suggest that a similar process may be involved in the modulation of hepatic glycogen repletion as well, and that this proposed homeostatic mechanism may be acting at the level of the glucose-6-phosphate pool. In fact, in the present study, consistent with a previous report by However, we cannot exclude that an increased hepatic delivery of gluconeogenic precursors may contribute to the preferential increase in the indirect pathway. Finally, the alteration in the pathways of hepatic glycogen formation may be the consequence ofthe chronic hypoinsulinemia, through the activation of the gluconeogenic enzymes (29, 82, 83) and the decrease in glucokinase activity (84) .
The present study provides a new quantitative approach to the measurement ofthe pathways of liver glycogen repletion in conscious rats. This methodology is particularly useful in conditions associated with high basal hepatic glycogen concentration, such as the fed or the diabetic states. Our data suggest that the glucose concentration is the major determinant of the relative contribution of the direct pathway to liver glycogen repletion in both control and diabetic rats. However, the presence of prolonged moderate hyperglycemia and hypoinsulinemia determines a marked reduction in the ability ofglucose to stimulate the direct pathway in this diabetic rat model. Nevertheless, the rates of hepatic glycogen synthesis were similar in diabetic and control rats, when measured at equal hyperglycemic and hyperinsulinemic levels. The increased gluconeogenic flux and a "push" mechanism for hepatic glycogen synthesis in diabetic rats may reconcile this apparent paradox. In conclusion, these results suggest that in the diabetic state a chronic activation of the carbon flux through the gluconeogenic pathway can promote glucose production or glycogen synthesis dependent on the hormonal and metabolic signal presented to the liver.
